0001415889-23-012532.txt : 20230823 0001415889-23-012532.hdr.sgml : 20230823 20230823130947 ACCESSION NUMBER: 0001415889-23-012532 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230821 FILED AS OF DATE: 20230823 DATE AS OF CHANGE: 20230823 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Anderson Cynthia Lynn CENTRAL INDEX KEY: 0001989905 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37761 FILM NUMBER: 231196512 MAIL ADDRESS: STREET 1: C/O VISTAGEN THERAPEUTICS, INC. STREET 2: 343 ALLERTON AVE. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Vistagen Therapeutics, Inc. CENTRAL INDEX KEY: 0001411685 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 205093315 STATE OF INCORPORATION: NV FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 343 ALLERTON AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-577-3600 MAIL ADDRESS: STREET 1: 343 ALLERTON AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: VistaGen Therapeutics, Inc. DATE OF NAME CHANGE: 20110610 FORMER COMPANY: FORMER CONFORMED NAME: Excaliber Enterprises, Ltd. DATE OF NAME CHANGE: 20070906 4 1 form4-08232023_050842.xml X0508 4 2023-08-21 0001411685 Vistagen Therapeutics, Inc. VTGN 0001989905 Anderson Cynthia Lynn C/O VISTAGEN THERAPEUTICS, INC. 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 false true false false CHIEF FINANCIAL OFFICER 0 Stock Option (right to buy) 5.34 2023-08-21 4 A 0 8333 0 A 2033-08-21 Common Stock 8333 8333 D 25% of the stock options vest on August 21, 2024 (the "Vesting Start Date") and 1/36th of the remaining number of shares vest monthly thereafter until all awarded shares are fully vested three (3) years after the Vesting Start Date. The stock options were granted in connection with the Reporting Person's appointment as Chief Financial Officer and pursuant to the Issuer's 2019 Omnibus Equity Incentive Plan. /s/ Cynthia L. Anderson 2023-08-23